Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CVS Point-Of-Sale Rebate Program Adopted By 'Several' Payers

Executive Summary

Manufacturer rebates can be used to reduce patient cost sharing at point of sale under the PBM's program. There is growing interest in the idea as a solution to lowering drug costs, but the practice could drive up insurance premiums.

You may also be interested in...



Medicare Part D Rebate Pass-Throughs To Beneficiaries Is 'On The Table'

Lilly CEO David Ricks reflects on the state of play on drug pricing issues on Capitol Hill and in the Administration and the challenges he sees ahead.

Point-Of-Sale Rebates In Part D: Study Highlights Trade-Offs For Medicare

Analysis funded by Pharmaceutical Care Management Association concludes that using drug rebates to lower beneficiary cost sharing at the point-of-sale would raise premiums and increase government spending.

Best Defense Is Good Offense: PhRMA Wants PBMs To 'Share The Savings'

PhRMA ad campaign targets US payer practice of using drug rebate dollars for general premium and cost sharing reductions and not to lower the cost of specific prescription fills.

Topics

Related Companies

UsernamePublicRestriction

Register

PS120885

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel